Siren, L.L.C. — SEC Form 4 filings

SEC reporting owner CIK 2005245. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-06.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-07-30 to 2026-02-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Scholar Rock Holding Corp (SRRK)10% owner36 legs · 2,009,433 sh · $82,397,6392
LEXICON PHARMACEUTICALS, INC. (LXRX)Director, 10% owner11 leg · 1,538,462 sh · $2,000,0013
GLYCOMIMETICS INC (GLYC)10% owner49 legs · 2,271,499 sh · $488,749

Form 4 filings — Siren, L.L.C.

FiledFormIssuerReported transactionsSource
2026-02-064Scholar Rock Holding Corp (SRRK)
jointly with Invus Global Management, LLC, DEBBANE RAYMOND
Option exercise/expiry (X): 1,575,008 @ $7.35 · Option exercise/expiry (X): 1,575,008 (derivative) @ $0EDGAR
2026-02-044LEXICON PHARMACEUTICALS, INC. (LXRX)
jointly with Invus Global Management, LLC, DEBBANE RAYMOND, Artal Participations S.a r.l., Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend
Grant/award (A): 18,553,846 @ $1.30 · Grant/award (A): 3,846,154 @ $1.30 · Purchase (P): 1,538,462 @ $1.30 · Grant/award (A): 367,145.12 @ $65EDGAR
2024-12-124Scholar Rock Holding Corp (SRRK)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 1,600,000 @ $41.65EDGAR
2024-11-274Scholar Rock Holding Corp (SRRK)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 208,272 @ $37.63 · Sale (S): 43,887 @ $38.43 · Sale (S): 126,442 @ $39.51 · Sale (S): 30,683 @ $40.14 · Sale (S): 149 @ $40.98EDGAR
2024-08-094GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 61,488 @ $0.18 · Sale (S): 260,873 @ $0.19EDGAR
2024-08-074GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 164,523 @ $0.19 · Sale (S): 55,732 @ $0.18EDGAR
2024-08-054GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 63,564 @ $0.22 · Sale (S): 286,200 @ $0.20EDGAR
2024-07-304GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, DEBBANE RAYMOND
Sale (S): 258,335 @ $0.24 · Sale (S): 363,949 @ $0.24 · Sale (S): 756,835 @ $0.22EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2005245 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →